Hinge Health Inc. (NYSE:HNGE - Free Report) - Investment analysts at KeyCorp issued their Q2 2025 earnings estimates for shares of Hinge Health in a report released on Monday, June 16th. KeyCorp analyst S. Schoenhaus expects that the company will post earnings of $0.09 per share for the quarter. KeyCorp has a "Overweight" rating and a $45.00 price objective on the stock. KeyCorp also issued estimates for Hinge Health's Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.55 EPS, Q1 2026 earnings at $0.08 EPS, Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.33 EPS, FY2026 earnings at $0.76 EPS, Q1 2027 earnings at $0.25 EPS and FY2027 earnings at $1.17 EPS.
Other equities research analysts also recently issued research reports about the company. Wall Street Zen raised Hinge Health to a "hold" rating in a research report on Monday, June 2nd. Needham & Company LLC initiated coverage on Hinge Health in a research report on Monday. They set a "buy" rating and a $47.00 target price for the company. Barclays began coverage on Hinge Health in a research report on Monday. They issued an "overweight" rating and a $43.00 price target on the stock. William Blair initiated coverage on Hinge Health in a research note on Monday. They issued an "outperform" rating for the company. Finally, Canaccord Genuity Group assumed coverage on shares of Hinge Health in a research note on Monday. They set a "buy" rating and a $52.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $46.00.
Get Our Latest Report on HNGE
Hinge Health Stock Up 4.7%
Shares of HNGE traded up $1.79 during mid-day trading on Wednesday, hitting $39.79. 771,425 shares of the company's stock were exchanged, compared to its average volume of 815,806. Hinge Health has a 52 week low of $33.42 and a 52 week high of $43.80.
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Further Reading
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
